Altium Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Altium Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3.78M	Buy	6,958 +722	+12%	+$397K	0.27%	50
2022 Q1	$3.68M	Buy	6,236 +533	+9%	+$306K	0.24%	52
2021 Q4	$3.81M	Buy	5,703 +416	+8%	+$260K	0.25%	50
2021 Q3	$3.02M	Buy	5,287 +64	+1%	+$35.1K	0.22%	54
2021 Q2	$2.63M	Buy	5,223 +49	+0.9%	+$23.1K	0.19%	59
2021 Q1	$2.36M	Buy	5,174 +254	+5%	+$121K	0.19%	62
2020 Q4	$2.29M	Buy	4,920 +152	+3%	+$71.3K	0.2%	56
2020 Q3	$2.1M	Buy	4,768 +120	+3%	+$49.6K	0.22%	54
2020 Q2	$1.68M	Buy	4,648 +66	+1%	+$22.1K	0.19%	62
2020 Q1	$1.3M	Buy	4,582 +1,243	+37%	+$392K	0.18%	68
2019 Q4	$1.08M	Buy	3,339 +401	+14%	+$122K	0.13%	90
2019 Q3	$856K	Buy	2,938 +154	+6%	+$44.1K	0.12%	108
2019 Q2	$818K	Sell	2,784 -23	-0.8%	-$6.33K	0.12%	108
2019 Q1	$768K	Sell	2,807 -61	-2%	-$15.2K	0.12%	114
2018 Q4	$642K	Buy	2,868 +57	+2%	+$13.4K	0.12%	121
2018 Q3	$686K	Buy	2,811 +89	+3%	+$20.5K	0.13%	120
2018 Q2	$564K	Buy	+2,722	New	+$578K	0.15%	106

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Altium Wealth Management's TMO Position: Q2 2022 in Review

Altium Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2022, buying an estimated $397K and bringing the position to 6,958 shares worth $3.78M. The position accounts for 0.27% of the portfolio, ranked #50.

Altium Wealth Management first reported a position in TMO in Q2 2018 and has held it in 17 quarters since. The position peaked at $3.81M in Q4 2021. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

Altium Wealth Management held 6,958 shares of Thermo Fisher Scientific worth $3.78M as of Q2 2022.
Altium Wealth Management bought 722 Thermo Fisher Scientific shares in Q2 2022, an estimated $397K.
Thermo Fisher Scientific made up 0.27% of Altium Wealth Management's portfolio in Q2 2022, its #50 holding.
Altium Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2018 and has held it in 17 quarters since.
Altium Wealth Management's Thermo Fisher Scientific position peaked at $3.81M in Q4 2021.
2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Altium Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.